Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges (Q36974685)

17 August 2017

1 reference

title

Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges (English)

1 reference

17 August 2017

multiple drug resistance

1 reference

Dexin Zhang

1

1 reference

PubMed ID

17944563

17 August 2017

Daiming Fan

series ordinal

2

1 reference

17 August 2017

1 October 2007

1 reference

Expert Review of Anticancer Therapy

17 August 2017

1 reference

17 August 2017

7

1 reference

17 August 2017

10

1 reference

17 August 2017

1369-1378

1 reference

Gastric cancer: standards for the 21st century

17 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Targeting multidrug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

A family of drug transporters: the multidrug resistance-associated proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Preoperative and adjuvant therapies for upper gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Mechanisms and strategies to overcome multiple drug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

The cytoplasmic trafficking of DNA topoisomerase IIalpha correlates with etoposide resistance in human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Clonal variability in CD95 expression is the major determinant in Fas-medicated, but not chemotherapy-medicated apoptosis in the RPMI 8226 multiple myeloma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

p21Waf1/Cip1 acts in synergy with bcl-2 to confer multidrug resistance in a camptothecin-selected human lung-cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

MDR1 gene expression and its clinical relevance in primary gastric carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Prediction of doxorubicin resistance in gastrointestinal cancer by P-glycoprotein staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Multidrug resistance-associated protein (MRP1) gene is strongly expressed in gastric carcinomas. Analysis by immunohistochemistry and real-time quantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

TRF2 promotes multidrug resistance in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Mad2beta, an alternative variant of Mad2 reducing mitotic arrest and apoptosis induced by adriamycin in gastric cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Depression of MAD2 inhibits apoptosis of gastric cancer cells by upregulating Bcl-2 and interfering mitochondrion pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Multidrug-resistance-associated protein MGr1-Ag is identical to the human 37-kDa laminin receptor precursor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Regulation of multidrug resistance by MGr1-antigen in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Overexpression of ZNRD1 promotes multidrug-resistant phenotype of gastric cancer cells through upregulation of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Regulation of drug sensitivity of gastric cancer cells by human calcyclin-binding protein (CacyBP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Regulation of multidrug resistance by ribosomal protein l6 in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Determinants of chemosensitivity in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Analysis of gene expression profiles in melanoma cells with acquired resistance against antineoplastic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

Chemotherapy sensitivity and resistance testing: to be "standard" or to be individualized, that is the question

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.10.1369

10.1586/14737140.7.10.1369

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17944563